The maker of ChloraPrep®, Medi-Flex, Inc., will begin operating as Enturia, Inc. effective Jan. 15, 2007. Aime Lenz, senior product manager, comments, Our company vision is about growth, innovation and improving healthcare. To achieve this vision, we are introducing new products, broadening our preventative scope, and expanding into international markets. We recognize that to be successful our strategy must begin at a fundamental levelwith our corporate identity and company name. Lenz adds that the company will also introduce a commitment to basically better health.
According to Lenz in a letter sent to customers, The name Enturia is inspired by three ideas centurion (signifying our commitment to providing protection from illness); venture (signifying our commitment to innovation); and endurance (signifying our commitment to the cause of basically better health). These ideas have developed over the last 21 years, and are a reflection of our dedication to retaining our core personality and values of delivering against our mission of basically better health. Lenz adds, We believe that good health is the cornerstone of human happiness. We see medicine as a human science and our role is to combine the clinical science with human understanding. These values involve combining competence with caring, while focusing on practitioner needs. Enturia, Inc. is a new name but at our core we remain the same company we have been for over 20 years. As Enturia moves into an exciting and promising future, we look forward to our continued partnership.
Source: Enturia, Inc.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.